Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder

Abstract Introduction Current WHO guidelines recommend using methadone or buprenorphine as maintenance treatments for maternal opioid use disorder. However, buprenorphine‐naloxone, with a lower abuse risk than buprenorphine monotherapy or methadone, offers a potentially beneficial alternative, but s...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Minna M. Kanervo, Sarimari J. Tupola, Eeva M. Nikkola, Krista M. Rantakari, Hanna K. Kahila
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-03-01
Edice:	Acta Obstetricia et Gynecologica Scandinavica
Témata:	buprenorphine buprenorphine‐naloxone maternal opioid use disorder methadone neonatal opioid withdrawal syndrome opioid maintenance treatment
On-line přístup:	https://doi.org/10.1111/aogs.14497
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!